Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005

Clinical Infectious Diseases

Volumn 47, Issue 2, 2008, Pages 168-175

  Hlavsa, Michele C ^a,b   Moonan, Patrick K ^b   Cowan, Lauren S ^b   Navin, Thomas R ^b   Kammerer, J Steve ^b,c   Morlock, Glenn P ^b   Crawford, Jack T ^b   LoBue, Philip A ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Northrup Grumman   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRAZINAMIDE; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; DISEASE TRANSMISSION; FEMALE; GENOTYPE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DAIRY PRODUCTS; DRUG RESISTANCE, BACTERIAL; EMIGRANTS AND IMMIGRANTS; FEMALE; GENOTYPE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PYRAZINAMIDE; RISK FACTORS; TUBERCULOSIS; UNITED STATES;

EID: 46349084946     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/589240     Document Type: Article

References (28)

1. Enarson DA. Introduction. In: Thoen CO, Steele JH, Gilsdorf MJ, eds. Mycobacterium bovis infections in animals and humans. 2nd ed. Ames, Iowa: Blackwell Publishing, 2006:1-5.
2. Thoen C, LoBue P, de Kantor I. The importance of Mycobacterium bovis as a zoonosis. Vet Microbiol 2006; 112:339-45.
3. Centers for Disease Control and Prevention. Human tuberculosis caused by Mycobacterium bovis - New York City, 2001-2004. MMWR Morb Mortal Wkly Rep 2005; 54:605-8.
4. Evans JT, Smith EG, Banerjee A, et al. Cluster of human tuberculosis caused by Mycobacterium bovis: evidence person-to-person transmission in the UK. Lancet 2007; 369:1270-6.
5. Guerrero A, Cobo J, Fortun J, et al. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet 1997; 350:1738-42.
6. Lo Bue P. Public health significance of M. bovis. In: Thoen CO, Steel JH, Gilsdorf MJ, eds. Mycobacterium bovis infections in animals and humans. 2nd ed. Ames, Iowa: Blackwell Publishing, 2006:6-12.
7. O'Reilly LM, Daborn CJ. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber Lung Dis 1995; 76(Suppl 1):S1-46.
8. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2006. Available at: http://www.cdc.gov/tb/surv/surv2006/pdf/ FullReport.pdf. Accessed 10 October 2007.
9. Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis 2001; 81:71-7.
10. de Jong BC, Onipede A, Pym AS, et al. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? J Clin Microbiol 2005; 43:3530-2.
11. Mycobacteria. In: Forbes BA, Sahm DF, Weissfeld AS, eds. Bailey and Scott's diagnostic microbiology. 10th ed. St. Louis, Missouri: Mosby, 1998:733-41.
12. Centers for Disease Control and Prevention. Guide to the application of genotyping to tuberculosis prevention and control. Available at: http://www.cdc.gov/tb/genotyping/manual.htm. Accessed 8 October 2007.
13. Cowan LS, Diem L, Monson T, et al. Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol 2005; 43:688-95.
14. Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6:23.
15. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35:907-14.
16. Desmond E, Ahmed AT, Probert WS, et al. Mycobacterium africanum cases, California. Emerg Infect Dis 2004; 10:921-3.
17. Hannan MM, Desmond EP, Morlock GP, Mazurek GH, Crawford JT. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States. J Clin Microbiol 2001; 39:647-50.
18. Brosch R, Gordon SV, Marmiesse M, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 2002; 99:3684-9.
19. Morlock GP, Crawford JT, Butler WR, et al. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44:2291-5.
20. Gibson AL, Hewinson G, Goodchild T, et al. Molecular epidemiology of disease due to Mycobacterium bovis in humans in the United Kingdom. J Clin Microbiol 2004; 42:431-4.
21. Cousins DV, Dawson DJ. Tuberculosis due to Mycobacterium bovis in the Australian population: cases recorded during 1970-1994. Int J Tuberc Lung Dis 1999; 3:715-22.
22. Baker MG, Lopez LD, Cannon MC, De Lisle GW, Collins DM. Continuing Mycobacterium bovis transmission from animals to humans in New Zealand. Epidemiol Infect 2006; 134:1068-73.
23. Robert J, Boulahbal F, Trystram D, et al. A national survey of human Mycobacterium bovis infection in France. Int J Tuberc Lung Dis 1999;3:711-4.
24. Milian-Suazo F, Salman MD, Ramirez C, Payeur JB, Rhyan JC, Santillan M. Identification of tuberculosis in cattle slaughtered in Mexico. Am J Vet Res 2000; 61:86-9.
25. Gilsdorf MJ, Ebel ED, Disney TW. Benefit and cost assessment of the U.S. bovine tuberculosis eradication program. In: Thoen CO, Steele JH, Gilsdorf MJ, eds. Mycobacterium bovis infections in animals and humans. 2nd ed. Ames, Iowa: Blackwell Publishing, 2006:89-99.
26. Harris NB, Payeur J, Bravo D, et al. Recovery of Mycobacterium bovis from soft fresh cheese originating in Mexico. Appl Environ Microbiol 2007; 73:1025-8.
27. Rigaud M, Borkowsky W. Tuberculosis in children. In: Rom WN, Garay SM, eds. Tuberculosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2004:609-24.
28. Besser RE, Pakiz B, Schulte JM, et al. Risk factors for positive Mantoux tuberculin skin tests in children in San Diego, California: evidence for boosting and possible foodborne transmission. Pediatrics 2001; 108:305-10.